Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 82868-019

2 FDA label images from Northwind Health Company, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 82868-019). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Bupropion Hydrochloride Sr 1)

Chemical Structure (Bupropion Hydrochloride Sr 1)
Chemical structure of bupropion hydrochloride shown with a chlorophenyl group, an acetyl group, and a tertiary amine group with three methyls, along with the hydrochloride component.*
FDA Label Image

Label (82868 019 90 Rev A 01 25 Nhc)

Label (82868 019 90   Rev A 01 25 Nhc)
Label for Bupropion Hydrochloride SR 150 mg extended-release tablets by Northwind Health Company, LLC. The package contains 90 film-coated tablets intended for oral use, with storage instructions to keep at 20°-25°C and protect from light and moisture. The label includes dosage form, strength, quantity, and manufacturer information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.